BioCentury | Apr 1, 2021
Management Tracks

Remembering Gilead’s John Martin, whose therapies saved ‘millions’

...absolutely a giant of our space,” said Stelios Papadopoulos...
...is absolutely a giant of our space.” Stelios Papadopoulos...
BioCentury | Aug 18, 2020
Product Development

I Want KaNDy, plus Sputnik V & M&A amid COVID-19: a BioCentury podcast

...key takeaways from a BioCentury-PJT Partners webinar on the topic.Fishburn zeroes in on comments from Stelios Papadopoulos...
...part of it, which is this growth of small companies and consolidation of those. And Stelios Papadopoulos...
BioCentury | Aug 14, 2020
Deals

Industry executives see M&A opportunities during COVID-19

...the $1-5 billion range.Biogen Inc. (NASDAQ:BIIB) Chairman Stelios Papadopoulos...
...is king, you will pay up significantly.” Stelios Papadopoulos...
BioCentury | Sep 14, 2019
Finance

Mark Schoenebaum: Setting the gold standard

...was genuine and he was truly one of a kind. We all miss him. -- Stelios Papadopoulos...
BioCentury | Jul 11, 2017
Financial News

Evelo raises $50M in series B round

...Flagship Pioneering and former CEO of the Novartis Pharmaceuticals division of Novartis AG (NYSE:NVS; SIX:NOVN); Stelios Papadopoulos...
BioCentury | May 20, 2017
Strategy

Henri: N of 1

...contract to produce the modified enzyme, alglucerase. Sidebar: It was about changing the world By Stelios Papadopoulos...
...be the beginning of celebrating Henri’s immeasurable contribution to the improvement of the human condition. Stelios Papadopoulos...
BioCentury | Feb 24, 2014
Company News

Biogen Idec board of directors update

...Retiring: Chairman William Young, effective at Biogen's 2014 annual meeting; he will be succeeded by Stelios Papadopoulos...
BioCentury | Feb 19, 2014
Company News

Biogen Idec Chairman Young to retire

...in June. Young has been a director since 1997 and was appointed chairman in 2010. Stelios Papadopoulos...
BioCentury | Jun 17, 2013
Company News

Regulus board of directors update

...Regulus Therapeutics Inc. (NASDAQ:RGLS), San Diego, Calif. Business: Infectious, Cancer, Cardiovascular Appointed: Stelios Papadopoulos as chairman; he...
BioCentury | Jan 9, 2012
Finance

More knowledge, less fluff

...enchantment with genomics waned when drug discovery and development timelines didn't change. But long-time biobanker Stelios Papadopoulos...
Items per page:
1 - 10 of 58
BioCentury | Apr 1, 2021
Management Tracks

Remembering Gilead’s John Martin, whose therapies saved ‘millions’

...absolutely a giant of our space,” said Stelios Papadopoulos...
...is absolutely a giant of our space.” Stelios Papadopoulos...
BioCentury | Aug 18, 2020
Product Development

I Want KaNDy, plus Sputnik V & M&A amid COVID-19: a BioCentury podcast

...key takeaways from a BioCentury-PJT Partners webinar on the topic.Fishburn zeroes in on comments from Stelios Papadopoulos...
...part of it, which is this growth of small companies and consolidation of those. And Stelios Papadopoulos...
BioCentury | Aug 14, 2020
Deals

Industry executives see M&A opportunities during COVID-19

...the $1-5 billion range.Biogen Inc. (NASDAQ:BIIB) Chairman Stelios Papadopoulos...
...is king, you will pay up significantly.” Stelios Papadopoulos...
BioCentury | Sep 14, 2019
Finance

Mark Schoenebaum: Setting the gold standard

...was genuine and he was truly one of a kind. We all miss him. -- Stelios Papadopoulos...
BioCentury | Jul 11, 2017
Financial News

Evelo raises $50M in series B round

...Flagship Pioneering and former CEO of the Novartis Pharmaceuticals division of Novartis AG (NYSE:NVS; SIX:NOVN); Stelios Papadopoulos...
BioCentury | May 20, 2017
Strategy

Henri: N of 1

...contract to produce the modified enzyme, alglucerase. Sidebar: It was about changing the world By Stelios Papadopoulos...
...be the beginning of celebrating Henri’s immeasurable contribution to the improvement of the human condition. Stelios Papadopoulos...
BioCentury | Feb 24, 2014
Company News

Biogen Idec board of directors update

...Retiring: Chairman William Young, effective at Biogen's 2014 annual meeting; he will be succeeded by Stelios Papadopoulos...
BioCentury | Feb 19, 2014
Company News

Biogen Idec Chairman Young to retire

...in June. Young has been a director since 1997 and was appointed chairman in 2010. Stelios Papadopoulos...
BioCentury | Jun 17, 2013
Company News

Regulus board of directors update

...Regulus Therapeutics Inc. (NASDAQ:RGLS), San Diego, Calif. Business: Infectious, Cancer, Cardiovascular Appointed: Stelios Papadopoulos as chairman; he...
BioCentury | Jan 9, 2012
Finance

More knowledge, less fluff

...enchantment with genomics waned when drug discovery and development timelines didn't change. But long-time biobanker Stelios Papadopoulos...
Items per page:
1 - 10 of 58